Evaluation of hypolipidemic properties of Murraya koenigii leaves studied in streptozotocin-induced diabetic rats

Biomedicine (India)

Volumn 29, Issue 3, 2009, Pages 220-225

  Subramanian, S ^a   Arulselvan, P ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Cholesterol; Diabetes; Lipoproteins; Murraya koenigii; Streptozotocin

Indexed keywords

EID: 84865373710     PISSN: 09702067     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Winer N and Sowers JR. Epidemiology of diabetes. J Clin Pharmacol 2004;44:397-405. (Pubitemid 38396785)
2. Halim EM and Hussain A. Hypoglycemic, hypolipidemic and antioxidant properties of combination of Curcumin from Curcuma longa. Linn, and partially purified product from Abroma augusla. Linn, in streptozotocin induced diabetes. Indian J Clin Biochem 2002;17:33-43.
3. Chakraborty DP, Barman BK and Bose PK. On the constitution of murrayanine, a carbazole derivative isolated from Murraya koenigii Spreng. Tetrahedron 1965;21:681-685.
4. Palaniswamy UR, Caporuscio C and Stuart JD. A chemical analysis of antioxidant vitamins in fresh curry leaf (Murraya koenigii) by reversed phase HPLC with UV detection. Acta Horticulturae 2003;620:475-478.
5. Dasgupta T, Rao AR and Yadava PK. Chemomodulatory action of curry leaf (Murraya koenigii) extract on hepatic and extrahepatic xenobiotic metabolising enzymes, antioxidant levels, lipid peroxidation, skin and f orestomach papillomagenesis. Nutr Res 2003;23:1427-1446. (Pubitemid 37243840)
6. Kesari AN, Kesari S, Singh SK, Gupta RK and Watal G. Studies on the glycemic and lipidemic effect of Murraya koenigii in experimental animals. J Ethnopharmacol 2007;112:305-311. (Pubitemid 46778961)
7. Ramsewak RS, Nair MG, Strasburg GM, DeWitt DL and Nitiss JL. Biologically active carbazole alkaloids from Murraya koenigii. J Agric Food Chem 1999;47:444-447. (Pubitemid 29185206)
8. Adebajo AC, Ayoola OF, Iwalewa EO, et al. Antitrichomonal, biochemical and toxicological activities of methanolic extract and some carbazole alkaloids isolated from the leaves of Murraya koenigii growing in Nigeria. Phytomedicine 2006;13:246-254. (Pubitemid 43255324)
9. Arulselvan P, Senthilkumar GP, Sathish Kumar D and Subramanian S. Anti-diabetic effect of Murraya koenigii leaves on streptozotocin induced diabetic rats. Pharmazie 2006;61:874-877. (Pubitemid 44622304)
10. Arulselvan P and Subramanian SP. Beneficial effects of Murraya koenigii leaves on antioxidant defense system and ultrastructural changes of pancreatic Beta-cells in experimental diabetes in rats. Chem Biol Interact 2007;165:155-164. (Pubitemid 46072799)
11. Arulselvan P and Subramanian S. Ultrastructural and biochemical abnormalities in the liver of streptozotocindiabetic rats: Protective effects of Murraya koenigii. J Phramacol Toxicol 2008;3:190-202. (Pubitemid 351850743)
12. Sasaki T, Matsy S and Sonae A. Effect of acetic acid concentration on the colour reaction in the O-toluidine boric acid method for blood glucose estimation. Rinsh Kagaku 1972;1:346-353.
13. Nayak SS and Pattabiraman TN. A new colorimetric method for the estimation of glycosylated hemoglobin. Clin Chim Acta 1981;109:267-274. (Pubitemid 11165574)
14. Folch J, Lees M and Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226:497-509.
15. Parekh AC and Jung DH. Cholesterol determination with ferric acetate-uranium acetate and sulphuric acid ferrous sulphate reagents. Anal Chem 1970;42:1423-1427.
16. Rice EW. In: Roedrick P and McDonal RP, editors. Standard methods in clinical chemistry. New York: Academic Press. 1970:215.
17. Hron WT and Menahan LA. A sensitive method for the determination of free fatty acids in plasma. J Lipid Res 1981;22:377-381. (Pubitemid 11125141)
18. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem 1959;234:466-468.
19. Hske CH and Subbarow Y. The colorimetricde termination of phosphorus J Biol Chem 1925;66:375-400.
20. Burstein M, Scholnick HR and Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970;11:583-595.
21. Friedewald WT, Levy RI and Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
22. Morrison WR and Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 1964;5:600-608.
23. Rhoads GG, Gulbrandsen CL and Kagan A. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N Engl J Med 1976;294:293-298.
24. Mamo JC, Hirano T, Sainsbury A, Fitzgerald AK and Redgrave TG. Hypertriglyceridemia is exacerbated by slow lipolysis of triacylglycerol-rich lipoproteins in fed but not fasted streptozotocin diabetic rats. Biochim Biophys Acta 1992;1128:132-138.
25. O'Looney P, Irwin D, Briscoe P and Vahouny GV. Lipoprotein composition as a component in the lipoprotein clearance defect in experimental diabetes. J Biol Chem 1985;260:428-432. (Pubitemid 15164068)
26. Laakso M. Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention. J Intern Med 2001;249:225-235. (Pubitemid 32417785)
27. Iyer UM and Mani UV. Studies on the effect of curry leaves supplementation (Murraya Koenigi) on lipid profile, glycated proteins' and amino acids in noninsulin-dependent diabetic patients. Plant Foods Hum Nutr 1990;40:275-282.
28. Gupta D, Raju J, Prakash J and Baquer NZ. Change in the lipid profile, lipogenic and related enzymes in the livers of experimental diabetic rats: effect of insulin and vanadate. Diabetes Res Clin Pract 1999;46:1-7. (Pubitemid 29474995)
29. Moller DE. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001;414:821-827. (Pubitemid 34000786)
30. Rawi SW, Abdel Moneim A and Ahmed OM. Studies on the effect of garlic oil and glibenclamide on alloxan diabetic rats. 1-hypoglycemic and histopathological effects. J Union Arab Biol 1996;6:121-142.
31. Xie JT, Chang WT, Wang CZ, et al. Curry leaf (Murraya koenigii Spreng.) reduces blood cholesterol and glucose levels in ob/ob mice. Am J Chin Med 2006;34:279-284.
32. Keane WF. The role of lipids in renal disease: future challenges. Kidney Int Suppl 2000;57:S27-S31. (Pubitemid 30205436)
33. Guijarro C, Kasiske BL, Kim Y, O'Donnell MP, Lee HS and Keane WF. Early glomerular changes in rats with dietary-induced hypercholesterolemia. Am J Kidney Dis 1995;26:152-161.
34. Cho SY, Park JY, Park EM, et al. Alternation of hepatic antioxidant enzyme activities and lipid profile in streptozotocin-induced diabetic rats by supplementation of dandelion water extract. Clin Chim Acta 2002;317:109-117.
35. Shin CS, Lee MK, Park KS, et al. Insulin restores fatty acid composition earlier in liver microsomes than erythrocyte membranes in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 1995;29:93-98.
36. Spector AA and Yorek MA. Membrane lipid composition and cellular function. J Lipid Res 1985;26:1015-1035. (Pubitemid 16258287)
37. Vessby B. Dietary fat and insulin action in humans. Br J Nutr 2000;83 Suppl 1:S91-S96. (Pubitemid 30319088)
38. Holman RT, Johnson SB, Gerrard JM, Mauer SM, Kupcho-Sandberg S and Brown DM. Arachidonic acid deficiency in streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 1983;80:2375-2379. (Pubitemid 13097192)
39. Poisson JP, Blond JP and Lemarchal P. Effect of the streptozotocin diabetes upon the in vivo conversion of [I-14C] gamma-linolenic and dihomo-gamma-linolenic acids into arachidonic acid in rats. Diabete Metab 1979;5:43-46. (Pubitemid 9151803)
40. Cameron NE and Cotter MA. Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res Clin Pract 1999;45:137-146. (Pubitemid 29457761)